中国麻风皮肤病杂志 ›› 2025, Vol. 41 ›› Issue (5): 368-371.doi: 10.12144/zgmfskin202505368

• 病例报告 • 上一篇    下一篇

药物超敏反应综合征并发普秃一例

张岸骅1,杨健康2,张晨3,乔洪江3,付萌3   

  1. 1 西安医学院,陕西西安,710021;2 空军第九八六医院皮肤烧伤整形科,陕西西安,710054;3 空军军医大学西京皮肤医院,陕西西安,710032
  • 出版日期:2025-05-15 发布日期:2025-05-15

Drug-induced hypersensitivity syndrome complicated with alopecia universalis: a case report

ZHANG Anhua1, YANG Jiankang2, ZHANG Chen3, QIAO Hongjiang3, FU Meng3   

  1. 1 Xi'an Medical University, Xi'an 710021, China; 2 Skin Burn and Plastic Surgery Department of Air Force 986 Hospital, Xi'an 710054, China; 3 Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi'an 710032, China
  • Online:2025-05-15 Published:2025-05-15

摘要: 有文献报道斑秃为药物超敏反应综合征的并发症,本文报道1例药物超敏反应综合征患者在皮疹出现6个月后出现并发症斑秃,并在2个月后逐渐发展为普秃。予巴瑞替尼治疗,2周后患者皮疹较前好转,但未见毛发明显生长。

关键词: 药物超敏反应综合征, 斑秃, 普秃, 自身免疫性疾病

Abstract: Some literature has reported that alopecia areata is a complication of drug hypersensitivity reaction syndrome. We report a case of a patient with drug-induced hypersensitivity syndrome who developed the complication of alopecia areata six months after the appearance of the rash, and gradually progressed to alopecia universalis two months later. After 2 weeks of treatment with baritinib, the rash was reduced, but no obvious hair growth was observed.

Key words: drug-induced hypersensitivity syndrome, alopecia areata, alopecia universalis, autoimmune diseases